We already have patients or customers in the HealthifyRx programme in the high-thousands and have a team of around 60 dietitians who were trained as part of our US business, where the semaglutides were available much earlier than India and thus had a greater exposure
Many countries in Europe and the United States have introduced strict policy for obesity drug approval mainly because of safety reasons
#ClinicalPharmacy #OncologyPharmacy #ASHP #Methotrexate #PatientSafety To view or add a comment, sign in 927 followers
Orforglipron had a similar safety profile as other GLP-1 receptor agonists. Trial outcomes For ATTAIN-2, researchers enrolled 1,613 adults aged 18 years and older with obesity or overweight plus one weight-related comorbidity, and with type 2 diabetes with an HbA1c between 7% and 10% at baseline (mean age, 56.8 years
If your RA medications are doing something but not enough, and your flares and fatigue keep coming back, there may be a metabolic piece of your puzzle no one has addressed yet
